A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.
Animal health giant Ceva Animal Health (Ceva) has struck a deal with London-based Touchlight for the use of the latter's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback